Literature DB >> 7548219

Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors.

H Watanabe1, K Fukuchi, Y Takagi, S Tomoyasu, N Tsuruoka, K Gomi.   

Abstract

We have screened for mutations in the Cip1/Waf1 gene using Southern blot analysis and the polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) method in diverse human tumors. Seven of 102 (7%) human tumor samples were identified to have point mutations within the coding region of the Cip1/Waf1 gene. Two of the seven mutated cases showed gene rearrangements. These results suggest that the frequency of genetic alterations in the Cip1/Waf1 gene is relatively low in comparison with several known tumor suppressor genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548219     DOI: 10.1016/0167-4781(95)00110-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Loss of nuclear p21(Cip1/WAF1) during neoplastic progression to metastasis in gamma-irradiated p21 hemizygous mice.

Authors:  Robert W Engelman; Rosalind J Jackson; Domenico Coppola; Walker Wharton; Alan B Cantor; W Jack Pledger
Journal:  Exp Mol Pathol       Date:  2007-01-04       Impact factor: 3.362

2.  The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transfection of a genomic clone containing the p21(WAF1/CIP1) gene.

Authors:  L A Allan; T Duhig; M Read; M Fried
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.

Authors:  M Sánchez-Beato; A I Sáez; J C Martínez-Montero; M Sol Mateo; L Sánchez-Verde; R Villuendas; G Troncone; M A Piris
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

Review 4.  Proteasome-dependent degradation of human CDC25B phosphatase.

Authors:  C Cans; B Ducommun; V Baldin
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

Review 5.  The role of the cell cycle in genitourinary carcinoma.

Authors:  T W McGarvey; S B Malkowicz
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

6.  Association of mutation and hypermethylation of p21 gene with susceptibility to breast cancer: a study from north India.

Authors:  Naseem Akhter; Md Salman Akhtar; Md Margoob Ahmad; Shafiul Haque; Sarah Siddiqui; Syed Ikramul Hasan; Nootan K Shukla; Syed Akhtar Husain
Journal:  Mol Biol Rep       Date:  2014-01-24       Impact factor: 2.316

7.  Lifestyle chemical carcinogens associated with mutations in cell cycle regulatory genes increases the susceptibility to gastric cancer risk.

Authors:  Ravi Prakash Yadav; Souvik Ghatak; Payel Chakraborty; Freda Lalrohlui; Ravi Kannan; Rajeev Kumar; Jeremy L Pautu; John Zomingthanga; Saia Chenkual; Rajendra Muthukumaran; Nachimuthu Senthil Kumar
Journal:  Environ Sci Pollut Res Int       Date:  2018-09-12       Impact factor: 4.223

8.  Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma.

Authors:  S Clasen; W A Schulz; C D Gerharz; M O Grimm; F Christoph; B J Schmitz-Dräger
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

9.  p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.

Authors:  S Mousses; N Gokgoz; J S Wunder; H Ozcelik; S Bull; R S Bell; I L Andrulis
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

10.  Sulforaphane Increases Cyclin-Dependent Kinase Inhibitor, p21 Protein in Human Oral Carcinoma Cells and Nude Mouse Animal Model to Induce G(2)/M Cell Cycle Arrest.

Authors:  Jun-Hee Kim; Ki Han Kwon; Ji-Youn Jung; Hye-Suk Han; Jung Hyun Shim; Sejun Oh; Kyeong-Hee Choi; Eun-Sun Choi; Ji-Ae Shin; Dae-Ho Leem; Yunjo Soh; Nam-Pyo Cho; Sung-Dae Cho
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.